Accordingly, a recent randomized clinical trial has demonstrated that drugs inhibiting the RAAS, including ACE inhibitors, significantly reduce the progression of myocardial fibrosis in patients with DMD or BMD (Silva et al., 2017), suggesting a deleterious role of ACE in DMD-related myocardial fibrosis. Here, ACE is linked to Duchenne muscular dystrophy.